VICTOR LORENZO MILLER
Pilots at Greenland Hideaway Dr, Jacksonville, FL
License number
Florida A5065297
Issued Date
Aug 2016
Expiration Date
Aug 2018
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
4964 Greenland Hideaway Dr N, Jacksonville, FL 32258
Professional information
Architect At United Airlines
Position:
Tools and Monitoring Architect at United Airlines
Location:
Jacksonville, Florida Area
Industry:
Information Technology and Services
Work:
United Airlines
- Greater Chicago Area since Aug 2012
-
Tools and Monitoring Architect
Education:
Florida State University 1988 - 1994
BS, Electrical Engineering
BS, Electrical Engineering
Skills:
IT Management, Application Performance Management, ITIL, IT Service Management, SiteScope, AppSight, Business Service Management, HP Business Availability Center, Configuration Management, HP Business Service Manager, IT Financial Management, Systems Management, Enterprise Architecture, HP, Integration, Cloud Computing, Application Lifecycle Management, SDLC, Enterprise Software, Data Center, Software Development, SaaS, Management, Security, Technical Architecture, Requirements Analysis, Solution Architecture, Leadership, SharePoint, Visio, Virtualization, SOA, Unix, Disaster Recovery, Information Technology, IT Strategy
Suppressing Polyglutamine Aggregation And Toxicity
US Patent:
2007024, Oct 18, 2007
Filed:
Jan 22, 2007
Appl. No.:
11/656048
Inventors:
Henry Paulson - Iowa City IA, US
Victor Miller - Jacksonville FL, US
Victor Miller - Jacksonville FL, US
International Classification:
A61K 38/07, A61K 38/06, A61P 25/28, C12N 5/06, C12N 5/08, C12N 5/10
US Classification:
514018000, 435375000
Abstract:
It has been discovered that CHIP suppresses polyglutamine aggregation and toxicity in transfected cell lines, primary neurons and a novel zebrafish model of disease. Accordingly, certain embodiments of the present invention provide methods for decreasing the formation of an inclusion or aggregation of a protein or for increasing the solubility of a protein in a cell, comprising increasing the amount of C-terminal heat shock protein 70-interacting protein (CHIP) or a functional subunit of CHIP in the cell. Additionally, certain embodiments of the present invention provide methods for treating a subject that has a neurodegenerative disease or preventing a neurodegenerative disease in a subject, comprising administering to the subject a treatment effective to increase the amount of CHIP, or a functional subunit thereof, in cells of the subject.